JP2009018038A - Multi-chambered container - Google Patents

Multi-chambered container Download PDF

Info

Publication number
JP2009018038A
JP2009018038A JP2007183172A JP2007183172A JP2009018038A JP 2009018038 A JP2009018038 A JP 2009018038A JP 2007183172 A JP2007183172 A JP 2007183172A JP 2007183172 A JP2007183172 A JP 2007183172A JP 2009018038 A JP2009018038 A JP 2009018038A
Authority
JP
Japan
Prior art keywords
bag
discharge port
drug
opened
plug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007183172A
Other languages
Japanese (ja)
Other versions
JP5141949B2 (en
Inventor
Chiharu Miyajima
千春 宮嶋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP2007183172A priority Critical patent/JP5141949B2/en
Publication of JP2009018038A publication Critical patent/JP2009018038A/en
Application granted granted Critical
Publication of JP5141949B2 publication Critical patent/JP5141949B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

<P>PROBLEM TO BE SOLVED: To provide a multi-liquid mixing type multi-chambered container for surely mixing medicaments when infusion is performed. <P>SOLUTION: A closing plug 30 is provided on an extension part to a medicament bag in a discharge port 12 and the discharge port 12 is normally in a closed state by the closing plug 30. A thin connecting plate 32 is integrally extended from the closing plug 30, and connection parts 36-1 and 36-2 separated by a slit 34 are strongly welded to the opposite inner layer of the medicament bag 10. The connection parts 36-1 and 36-2 are expanded and displaced by the expansion and displacement of a medical fluid bag when the partition of the medicament bag is opened, the closing plug 30 is moved along the discharge port 12 and detached from the discharge port, and thus the discharge port 12 is opened. <P>COPYRIGHT: (C)2009,JPO&INPIT

Description

この発明は輸液に使用される多液混合型の複室容器に関し、輸液の際に薬剤の確実な混合を行い得るようにしたものである。   The present invention relates to a multi-component mixed-type multi-chamber container used for infusion, and is capable of reliably mixing medicines at the time of infusion.

輸液用複室容器において、ポリエチレン等を素材とする軟弱フィルムより成る薬剤バッグの対向面を相対的に低温にて加圧剥離可能に溶着して成る隔壁(弱シール部)によって、薬液バッグ内部を夫々異なった薬液を収容する複数の隔室に分離したものがある。薬剤バッグの外周には、プラスチック成型品としての排出ポートが設けられ、排出ポートは筒状に形成され、その内部空洞は一端側で一方の隔室に開口しているが、他端にはゴム栓が設けられている。患者への薬液の投与に先立って薬剤バッグを外側から加圧することによって弱シール部が剥離開通せしめられ、薬剤バッグの内部空洞は一室となるため2種類の薬液は混合され、輸液セットの穿刺針によりゴム栓を穿刺し、薬剤バッグよりの薬液の投与が可能となる。従って、この種の医療用混合型複室容器においては薬液の投与に先立って弱シール部の剥離開通により両液を混合せしめる作業は必須であり、他方、弱シール部の開通を行わないままで排出ポートにおけるゴム栓の穿刺を行うと、排出ポート側の隔室における薬液のみが投与されてしまうという誤操作の可能性があった。この問題点に対処する従来技術として、通常時は排出ポートを閉鎖するが、隔壁開通時の薬液バッグ内圧に応じ開通・移動する可動部材や栓体を設けたものが提案されている(特許文献1及び2)。
特開2003−305107号公報 特開2005−28040号公報
In a multi-chamber container for infusion, the inside of the drug solution bag is separated by a partition wall (weak seal part) formed by welding the opposite surface of a drug bag made of a soft film made of polyethylene or the like so that it can be peeled off at a relatively low temperature. Some are separated into a plurality of compartments each containing different chemicals. A discharge port as a plastic molded product is provided on the outer periphery of the medicine bag, the discharge port is formed in a cylindrical shape, and the internal cavity opens to one compartment on one end side, but the other end has a rubber A stopper is provided. Prior to administration of the drug solution to the patient, the weak seal is peeled open by pressurizing the drug bag from the outside, and the drug bag has an internal cavity so that the two types of drug solutions are mixed and the infusion set is punctured A rubber stopper is punctured with a needle, and a drug solution can be administered from a drug bag. Therefore, in this type of medical mixed-type multi-chamber container, it is essential to mix the two liquids by peeling and opening the weak seal portion prior to the administration of the chemical solution, while the weak seal portion is not opened. When the rubber stopper is punctured at the discharge port, there is a possibility of an erroneous operation in which only the drug solution in the compartment on the discharge port side is administered. As a conventional technique for dealing with this problem, there has been proposed a technique in which a discharge port is normally closed, but a movable member and a stopper that are opened and moved according to the internal pressure of the chemical solution bag when the partition wall is opened are provided (Patent Literature). 1 and 2).
JP 2003-305107 A JP-A-2005-28040

特許文献1及び2の技術では隔壁破断・開通時において薬液バッグ内に生ずる薬液圧力を可動部材や栓体に加えることで可動部材や栓体を移動させることにより排出ポートを開通に至らせている。即ち、可動部材や栓体にはその受圧面積×開通時の薬液バッグ内圧力の力が加わり、この力によって可動部材や栓体は移動せしめられる。しかしながら、可動部材や栓体は排出ポートに設けられており、その受圧面積は最大排出ポートの内径に限定され、あまり大きな受圧面積とはならない。そのため、開通移動させるべく可動部材や栓体に加わる力はあまり大きくならず、所期の移動動作が得られず、隔壁開通と排出ポートの開通を連動させられず、隔壁開通にもかかわらず排出ポートは閉じたままということが起こりえていた。   In the techniques of Patent Documents 1 and 2, the discharge port is opened by moving the movable member and the plug body by applying the chemical pressure generated in the chemical bag to the movable member and the plug body when the partition wall is broken and opened. . That is, the force of the pressure receiving area × the pressure in the chemical solution bag at the time of opening is applied to the movable member and the plug, and the movable member and the plug are moved by this force. However, the movable member and the plug are provided in the discharge port, and the pressure receiving area is limited to the inner diameter of the maximum discharge port, and the pressure receiving area is not so large. For this reason, the force applied to the movable member and the plug body to move the opening is not so great, the desired movement cannot be obtained, the opening of the partition wall and the opening of the discharge port cannot be linked, and the discharge is performed despite the opening of the partition wall. It was happening that the port remained closed.

この発明は以上の問題点に鑑みてなされたものであり、隔壁未開通状態において排出ポートを閉鎖する閉鎖部材を備えた複室容器において、閉鎖隔壁開通時に閉鎖部材を排出ポートから確実に離脱せしめ、排出ポートを開放させるようにすることを目的とする。   The present invention has been made in view of the above problems, and in a multi-chamber container provided with a closing member that closes the discharge port when the partition wall is not opened, the closing member is securely detached from the discharge port when the closed partition wall is opened. The purpose is to open the discharge port.

この発明の複室容器は、軟弱フィルムにて形成された薬液バッグと、薬液バッグの対向面を加圧剥離可能に溶着することにより薬剤バッグの内部を複数の隔室に分離する隔壁と、薬液バッグに固定され、一端が薬液バッグの内部に延出し、薬液バッグの外側に位置する他端に穿刺のための栓体を具備した排出ポートと、薬剤バッグの内部に延出した排出ポートの前記一端に密実に若しくは多少の隙間にて移動可能に設けられ、通常は排出ポートの前記一端に挿入されている閉鎖部材と、隔壁開通時の薬液バッグ拡開変位に純機械的に連動して前記閉鎖部材を排出ポートから離脱移動せしめるべく前記閉鎖部材を薬液バッグを構成する軟弱フィルム内面に溶着にて連結する薄肉板材や、リンクや、レバーや、紐状体等連結具とから構成される。   The multi-chamber container of the present invention includes a chemical solution bag formed of a soft film, a partition wall that separates the inside of the drug bag into a plurality of compartments by welding the opposing surfaces of the chemical solution bag so as to be capable of being pressure-released, and a chemical solution. The discharge port, which is fixed to the bag, has one end extending into the drug solution bag, the other end located outside the drug solution bag having a stopper for puncturing, and the discharge port extending into the drug bag. A closing member, which is provided at one end so as to be able to move densely or with a slight gap, and which is normally inserted at the one end of the discharge port, and in conjunction with the expansion of the chemical bag when the partition is opened, is purely mechanically linked to the above-mentioned In order to move the closing member away from the discharge port, the closing member is composed of a thin plate material, a link, a lever, a string-like member, and the like, which are connected to the inner surface of the soft film constituting the chemical solution bag by welding.

この発明では排出ポートに移動可能に設けられた閉鎖部材は通常は排出ポートを閉鎖しており、閉鎖部材は連結具によって薬剤バッグに連結され、薬剤バッグの開通時の膨れ変位に純機械的に連動して閉鎖部材は排出ポートから離脱するように移動せしめられる。   In the present invention, the closing member movably provided at the discharge port normally closes the discharge port, and the closing member is connected to the drug bag by a connector so that the swell displacement at the opening of the drug bag is purely mechanical. In conjunction with this, the closing member is moved away from the discharge port.

この発明によれば開閉部材は隔壁開通時の薬液バッグ拡開変位にメカニカルに連動して排出ポートから離脱するように移動せしめられるため、隔壁開通時に排出ポートを確実に開放させることができ、効率的でかつ所期の輸液操作をいつも行うことができる。   According to the present invention, since the opening / closing member is moved so as to be detached from the discharge port mechanically in conjunction with the expansion of the chemical bag when the partition wall is opened, the discharge port can be reliably opened when the partition wall is opened. The intended and intended infusion operation can always be performed.

図1から図4において、複室容器は薬液の収納のための平坦状の薬剤バッグ10と、筒状排出ポート12とから構成される。薬剤バッグ10は厚さ200ミクロンといったポリエチレンフィルムなどの多層構造の合成樹脂軟弱フィルム(本発明の軟弱フィルム若しくは可撓性フィルム)を素材とする。薬剤バッグ10を構成する一対の合成樹脂軟弱フィルムは筒状排出ポート12を挟んで重ねられ、全外周部がポリエチレンの場合は130℃といった高温で溶着され、筒状排出ポート12の部位も含めた全周に沿った強シール部14を形成する。筒状排出ポート12以外の部位での溶着はポリエチレンフィルム同士であり、筒状排出ポート12の部位での溶着は筒状排出ポート12とポリエチレンフィルムとであり、同時には溶着できないので、別工程で溶着(強シール)が実施され、筒状排出ポート12での強シール部を残余の部位でのそれと区別するため14-1にて示す。強シール部14及び14-1での溶着は薬剤バッグ10の開通ため加圧したときの薬剤バッグ内に生ずる程度の圧力では剥離するようなことはないような温度(ポリエチレンの場合は前述のように130℃程度)で行われ、これにより外部からの物理的な力の影響にかかわらず、薬剤バッグ10内に薬液を漏洩することなく保持することができる。強シール部14には薬剤バッグを輸液台に懸架するための丸孔15が設けられる。   1 to 4, the multi-chamber container includes a flat drug bag 10 for storing a chemical solution and a cylindrical discharge port 12. The drug bag 10 is made of a synthetic resin soft film (a soft film or a flexible film of the present invention) having a multilayer structure such as a polyethylene film having a thickness of 200 microns. A pair of synthetic resin soft films constituting the drug bag 10 are stacked with the cylindrical discharge port 12 interposed therebetween, and when the entire outer peripheral portion is made of polyethylene, it is welded at a high temperature of 130 ° C., and the portion of the cylindrical discharge port 12 is also included. A strong seal portion 14 is formed along the entire circumference. Welding at parts other than the cylindrical discharge port 12 is between polyethylene films, and welding at the part of the cylindrical discharge port 12 is between the cylindrical discharge port 12 and the polyethylene film, and cannot be welded at the same time. Welding (strong sealing) is carried out, and the strong sealing portion at the cylindrical discharge port 12 is indicated by 14-1 to distinguish it from that at the remaining portion. The welding at the strong seal portions 14 and 14-1 is a temperature at which the pressure does not peel at the pressure generated in the drug bag when the drug bag 10 is pressurized to open the drug bag 10 (as described above in the case of polyethylene). Thus, regardless of the influence of external physical force, the drug solution can be held in the drug bag 10 without leaking. The strong seal portion 14 is provided with a round hole 15 for suspending the drug bag on the infusion table.

筒状排出ポート12はその筒形状を維持することができる肉厚(剛性)のプラスチック成形品として構成される。筒状排出ポート12は図1の下端で薬剤バッグ10から突出しており、薬剤バッグ10の下端から突出する筒状排出ポート12の下端に、輸液時に輸液セットの穿刺針により穿刺されるゴム栓20(栓体)が装着されている。   The cylindrical discharge port 12 is configured as a thick (rigid) plastic molded product capable of maintaining its cylindrical shape. The cylindrical discharge port 12 protrudes from the drug bag 10 at the lower end of FIG. 1, and a rubber plug 20 is inserted into the lower end of the cylindrical discharge port 12 protruding from the lower end of the drug bag 10 by the puncture needle of the infusion set at the time of infusion. (Plug) is attached.

薬剤バッグ10を構成する2枚の合成樹脂フィルム層は薬剤バッグ10の長手方向(図1の上下方向)の中間部位で全幅にて加圧剥離可能に溶着され、弱シール部24(本発明の隔壁)を構成する。弱シール部24によって薬剤バッグ10の内部空洞は図1の上下における第1及び第2の隔室26, 28に分離され、第1及び第2の隔室26, 28に夫々第1及び第2の薬液を分離状態で収納することができる。弱シール部24における、薬剤バッグ10を構成する上下の合成樹脂フィルム層の溶着は加圧剥離可能である。加圧剥離可能とは、薬剤バッグ10の開通のため薬剤バッグ10を手のひらなどで適当な力で加圧したとき、薬剤バッグ10内に生ずる液体圧力による膨れ(拡開変形)で弱シール部24において上下フィルム層が剥離されることを意味し、この発明の実施形態におけるポリエチレン樹脂の場合は弱シール部24での溶着は120℃(強シール部14を得るための前記した130℃といった溶着温度より相当低い溶着温度)といった温度にて行われる。弱シール部24の開通による排出ポート12付近における薬液バッグの拡開状態が図4に示されている。   The two synthetic resin film layers constituting the drug bag 10 are welded so as to be capable of being pressure peeled at the full width at an intermediate portion in the longitudinal direction (vertical direction in FIG. 1) of the drug bag 10, and the weak seal portion 24 (of the present invention). Partition). The inner cavity of the medicine bag 10 is separated into the first and second compartments 26 and 28 in the upper and lower parts of FIG. 1 by the weak seal portion 24, and the first and second compartments 26 and 28 are separated into the first and second compartments, respectively. Can be stored in a separated state. Welding of the upper and lower synthetic resin film layers constituting the drug bag 10 in the weak seal portion 24 can be performed by pressure peeling. The pressure peelable means that when the drug bag 10 is pressed with an appropriate force with a palm or the like for opening the drug bag 10, the weak seal portion 24 is caused by swelling (expanding deformation) due to liquid pressure generated in the drug bag 10. Means that the upper and lower film layers are peeled off, and in the case of the polyethylene resin in the embodiment of the present invention, the welding at the weak seal portion 24 is 120 ° C. (the welding temperature such as 130 ° C. described above for obtaining the strong seal portion 14). At a much lower welding temperature). FIG. 4 shows an expanded state of the chemical solution bag in the vicinity of the discharge port 12 due to the opening of the weak seal portion 24.

図2において、排出ポート12は筒状をなし、拡開形状の外側端部に別体のキャップ12-1が溶着にて一体化され、ゴム栓20はキャップ12-1に取付けられている。排出ポート12の内側端部は先細部12-2を呈し、その外周に強シール部14-1が位置され、かつ薬液バッグ内部まで延設されている。排出ポート12の先細部12-2の内周にディスク状の閉止栓30(本発明の開閉部材)が排出ポートの長手方向(軸線方向)に摺動可能に配置される。閉止栓30は適当なプラスチック若しくはゴム素材にてディスク状に成形され、排出ポート12から離間方向に、即ち、薬液バッグ内部空洞に向け片持状に延出する、一体成形の薄肉連結板32(この発明の連結具)を形成している。薄肉連結板32に閉止栓30の少し手前から端面まで長手方向に伸びるスリット34が設けられ、このスリット34により薄肉連結板32は第1連結部36-1と第2連結部36-2とに分割される。第1連結部36-1及び第2連結部36-2は、閉止栓30から離間側端部36-1', 36-2'が幾分拡開され、この拡開端部36-1', 36-2'は薬剤バッグ10の上下層の対向内面に強固に溶着される。図3に拡開端部36-1', 36-2'における薬液バッグ対向層との溶着部を斜線領域38-1, 38-2により示しており、溶着38-1, 38-2はレーザ溶着等により実施することができる。レーザ溶着の際の溶着温度は薬液バッグ10の外周の強シール部14の溶着温度と同程度であり、そのため、隔壁を構成する弱シール部24の開通時に、薬液バッグ中の薬液に加わる流体圧力では剥離することがなく、拡開端部36-1', 36-2'と薬液バッグ上下層との溶着は保持されるようになっている。そして、薄肉連結板32の肉厚は弱シール部24の開通時の薬液バッグ10の拡開変形に追随して第1連結部36-1及び第2連結部36-2が変位するようなフレキシビリテイは提供するがその伸張・破断は実質的に生じせしめないように適宜に設定される。   In FIG. 2, the discharge port 12 has a cylindrical shape, and a separate cap 12-1 is integrated by welding at the outer end of the expanded shape, and the rubber plug 20 is attached to the cap 12-1. The inner end portion of the discharge port 12 has a tapered portion 12-2, a strong seal portion 14-1 is positioned on the outer periphery thereof, and extends to the inside of the chemical solution bag. A disc-shaped closing plug 30 (opening / closing member of the present invention) is disposed on the inner periphery of the tapered portion 12-2 of the discharge port 12 so as to be slidable in the longitudinal direction (axial direction) of the discharge port. The stopper plug 30 is formed into a disk shape from a suitable plastic or rubber material, and is integrally formed with a thin-walled connecting plate 32 (cantilevered from the discharge port 12 in a direction away from the discharge port 12, that is, toward the internal cavity of the drug solution bag. Forming the connector of the present invention). The thin connecting plate 32 is provided with a slit 34 extending in the longitudinal direction from a little before the end plug 30 to the end surface, and the thin connecting plate 32 is divided into the first connecting portion 36-1 and the second connecting portion 36-2 by the slit 34. Divided. The first connecting portion 36-1 and the second connecting portion 36-2 have the side end portions 36-1 ′ and 36-2 ′ somewhat expanded from the stopper plug 30, and the expanded end portions 36-1 ′, 36-2 ′ is firmly welded to the opposing inner surfaces of the upper and lower layers of the drug bag 10. Fig. 3 shows the welded portions of the expanded end portions 36-1 'and 36-2' with the chemical solution bag facing layer by hatched regions 38-1 and 38-2. The welds 38-1 and 38-2 are laser welded. Etc. can be implemented. The welding temperature at the time of laser welding is approximately the same as the welding temperature of the strong seal portion 14 on the outer periphery of the chemical solution bag 10, and therefore, the fluid pressure applied to the chemical solution in the chemical solution bag when the weak seal portion 24 constituting the partition wall is opened. Then, there is no peeling, and the welding between the expanded end portions 36-1 'and 36-2' and the upper and lower layers of the chemical solution bag is maintained. The thickness of the thin connection plate 32 is such that the first connection portion 36-1 and the second connection portion 36-2 are displaced following the expansion deformation of the chemical bag 10 when the weak seal portion 24 is opened. It is set appropriately so as to provide the billiness but not substantially cause the extension / breakage.

弱シール部24の開通は、薬剤バッグ10を机などの上に平坦に載置し、薬剤バッグ10を手のひらで加圧することにより行われる。即ち、加圧により加わる薬液の圧力により弱シール部24において薬剤バッグ10の両層が分離し(弱シール部24が分離した状態を図4に示す)、隔室26, 28は一体となり、それまで隔室26, 28に分離収容されていた薬液は混合される。そして、弱シール部24の開通により高められた薬液の圧力は排出ポート12との接続部位で薬液バッグ10を図4のように拡開せしめ、薄肉連結板32は第1及び第2連結部36-1, 36-2の端部36-1', 36-2'で薬剤バッグ10の対向内層に剥離不能に溶着されているため、第1及び第2連結部36-1, 36-2も薬剤バッグの拡開に連動して拡開せしめられ、その結果、閉止栓30は排出ポート12の軸線に沿って薬剤バッグ10の内側に移動することで排出ポート12の開口端面から離脱せしめられ、排出ポート12は排出ポート12の開口端を介して薬液バッグ10の内部に連通せしめられ、混合薬液を排出ポート12に流入せしめられ、排出ポート下端のゴム栓に輸液セットの穿刺針(図示しない)を穿刺することで、輸液を開始することができる。   The weak seal portion 24 is opened by placing the drug bag 10 flat on a desk or the like and pressurizing the drug bag 10 with the palm of the hand. That is, both layers of the drug bag 10 are separated at the weak seal portion 24 by the pressure of the chemical solution applied by pressurization (the state where the weak seal portion 24 is separated is shown in FIG. 4), and the compartments 26 and 28 are integrated, The chemicals separated and accommodated in the compartments 26 and 28 are mixed. And the pressure of the chemical | medical solution raised by opening of the weak seal part 24 expands the chemical | medical solution bag 10 like FIG. 4 in the connection site | part with the discharge port 12, and the thin connection board 32 is the 1st and 2nd connection part 36. -1 and 36-2 end portions 36-1 'and 36-2' are welded to the opposite inner layer of the drug bag 10 so as not to be peeled off, so that the first and second connecting portions 36-1 and 36-2 are also As a result, the stopper plug 30 is disengaged from the opening end surface of the discharge port 12 by moving to the inside of the drug bag 10 along the axis of the discharge port 12. The discharge port 12 is communicated with the inside of the drug solution bag 10 through the opening end of the discharge port 12, the mixed drug solution is allowed to flow into the discharge port 12, and the puncture needle (not shown) of the infusion set is inserted into the rubber stopper at the lower end of the discharge port. Infusion can be started by puncturing.

図3において、薄肉連結板32の第1及び第2連結部36-1, 36-2において拡開端部36-1', 36-2'の付根付近に幅方向に延びるように薄肉部40-1, 40-2が連結板32の肉厚を更に薄肉化するように設けられる。薄肉部40-1, 40-2を設けることで、この部位での容易屈曲性により排出ポートから離脱後に閉止栓30が溶着部より上に浮かぶため、排出ポートが閉止栓30により再び閉塞されてしまうようなことが回避される。   In FIG. 3, in the first and second connecting portions 36-1 and 36-2 of the thin connecting plate 32, the thin portion 40- extends so as to extend in the width direction near the roots of the expanded end portions 36-1 'and 36-2'. 1, 40-2 are provided so as to further reduce the thickness of the connecting plate 32. By providing the thin-walled portions 40-1 and 40-2, the closure plug 30 floats above the welded portion after detachment from the discharge port due to easy bending at this portion, so that the discharge port is closed again by the closure plug 30. Is avoided.

この実施形態において、スリット34の代わりに薄肉部として、開通時にこの薄肉部が開通時の薬液バッグの膨れ変形により破裂せしめられるようにしても良い。   In this embodiment, instead of the slit 34, a thin portion may be formed so that the thin portion may be ruptured by bulging deformation of the chemical solution bag at the time of opening.

図5及び図6は第2の実施形態を示しており、この実施形態では排出ポート12を閉鎖する閉止栓30を弱シール部24(隔壁)開通時の薬液バッグ10の膨れ変形に連動せしめる連結具を内蔵バッグ42により構成している。内蔵バッグ42は上下の合成樹脂フィルム44-1, 44-2から構成され、上下のフィルム44-1, 44-2は外周部46にて剥離可能に溶着され、その内側において上下のフィルム44-1, 44-2間に少量薬剤のための小隔室48(第3室)が形成され、小隔室48内に隔室26, 28に収容される輸液薬剤に添加するべき少量薬剤が収納されている。外周部46での溶着温度は薬液バッグ10の弱シール部24のそれと同程度であり、薬液バッグ開通時に剥離開通されるようになっている。内蔵バッグ42を構成する合成樹脂フィルムは44-1, 44-2は排出ポート12側の一端は閉止栓30と一体となっており、他端(剥離可能溶着部46からの延出部位)44-1', 44-2'は薬液バッグ10と対向したフィルム内面に強固に溶着されており、この強溶着部を図5で50にて示す。この際の強溶着部50の溶着温度は薬液バッグ10外周の強シール部14の溶着温度と同程度であり、薬液バッグ開通時にも剥離されることがなく溶着状態を維持することができる。   5 and 6 show the second embodiment. In this embodiment, the connection plug 30 that closes the discharge port 12 is interlocked with the swelling deformation of the drug solution bag 10 when the weak seal portion 24 (partition wall) is opened. The tool is constituted by a built-in bag 42. The built-in bag 42 is composed of upper and lower synthetic resin films 44-1, 44-2. The upper and lower films 44-1, 44-2 are welded to the outer peripheral portion 46 so as to be peeled off, and the upper and lower films 44- A small compartment 48 (third chamber) is formed between 1 and 44-2, and a small amount of medicine to be added to the infusion medicine contained in compartments 26 and 28 is stored in the compartment 48. Has been. The welding temperature at the outer peripheral portion 46 is approximately the same as that of the weak seal portion 24 of the chemical solution bag 10, and is peeled off when the chemical solution bag is opened. The synthetic resin films 44-1 and 44-2 constituting the built-in bag 42 are integrated with the stopper plug 30 at one end on the discharge port 12 side, and the other end (extended portion from the peelable weld 46) 44. -1 'and 44-2' are firmly welded to the inner surface of the film facing the chemical solution bag 10, and this strongly welded portion is indicated by 50 in FIG. At this time, the welding temperature of the strong welding part 50 is approximately the same as the welding temperature of the strong seal part 14 on the outer periphery of the chemical liquid bag 10, and the welding state can be maintained without being peeled even when the chemical liquid bag is opened.

図6(イ)は薬液バッグ未開通時を示しており、内蔵バッグ42は閉鎖状態にあり、小隔室48に少量薬剤が収納される。他方、閉止栓30は排出ポート12を実質的に閉鎖している。   FIG. 6 (a) shows a state in which the medical solution bag is not opened. The built-in bag 42 is in a closed state, and a small amount of medicine is stored in the small compartment 48. On the other hand, the closure plug 30 substantially closes the discharge port 12.

図6(ロ)は隔壁開通時を示しており、薬液バッグ10中の薬液は外部から加圧され、弱シール部(隔室)24が開通される。弱シール部24の開通による薬液バッグ10の膨れ変形は、内蔵バッグ42を構成する合成樹脂フィルム44-1, 44-2の端部44-1', 44-2'が薬液バッグ10の対向内層に強固に溶着されていることから、内蔵バッグ42の外周の剥離可能溶着部46が剥離され、合成樹脂フィルム44-1, 44-2が分離されるため、内蔵バッグ42の小隔室48が薬液バッグ10に開口され、少量薬剤は隔室26, 28からの混合薬液と混合される。同時に、薬液バッグ10の膨れによる合成樹脂フィルム層の外方への変位は合成樹脂フィルム44-1, 44-2によりそのまま(メカニカルに)閉止栓30に伝達され、閉止栓30は排出ポート12から離脱せしめられ、薬剤は排出ポート12に流入せしめられる。   FIG. 6 (b) shows when the partition wall is opened. The chemical solution in the chemical solution bag 10 is pressurized from the outside, and the weak seal portion (compartment) 24 is opened. The swelling of the chemical solution bag 10 due to the opening of the weak seal portion 24 is caused by the end portions 44-1 'and 44-2' of the synthetic resin films 44-1 and 44-2 constituting the internal bag 42 facing the inner layer of the chemical solution bag 10. Since the peelable welded portion 46 on the outer periphery of the built-in bag 42 is peeled off and the synthetic resin films 44-1 and 44-2 are separated, the small compartment 48 of the built-in bag 42 is formed. The drug solution bag 10 is opened, and a small amount of drug is mixed with the mixed drug solution from the compartments 26 and 28. At the same time, the outward displacement of the synthetic resin film layer due to the swelling of the chemical solution bag 10 is transmitted to the closing plug 30 as it is (mechanically) by the synthetic resin films 44-1 and 44-2, and the closing plug 30 is discharged from the discharge port 12. Withdrawn, the drug flows into the discharge port 12.

図6(ハ)は隔壁開通後の状態を示し、分離した閉止栓30はプラスチック製で比重としては小さくかつ合成樹脂フィルム44-1, 44-2も軟弱であるため薬液バッグ10中の薬液に浮かび、排出ポート12から離間され、排出ポート12が閉塞されてしまう懸念はない。   FIG. 6 (c) shows a state after the partition wall is opened. The separated stopper plug 30 is made of plastic, has a small specific gravity, and the synthetic resin films 44-1 and 44-2 are also soft. There is no concern that it will float, be separated from the discharge port 12, and be blocked.

図7は第3の実施形態を示し、この実施形態では排出ポート12を閉鎖する閉止栓30を弱シール部24(隔壁)開通時の薬液バッグ10の膨れ変形に連動せしめる連結具を合成樹脂製リンク機構52によって構成している。リンク機構52は、閉止栓30と一体成形の板状部(レバー)54と、板状部54に枢軸55にて回動可能に連結された第1及び第2のリンク56-1, 56-2と、第1及び第2のリンク56-1, 56-2に枢軸58-1, 58-2にて枢着され、薬液バッグ10を構成するプラスチックフィルム対向層と強固に(剥離不能に)溶着される取付板60-1, 60-2とから構成される。枢軸55、リンク56-1, 56-2、枢軸58-1, 58-2、取付板60-1, 60-2は閉止栓30と同様の軽量プラスチック素材にて形成される。レバー54とリンク56-1, 56-2との長さ比を適当にとることにより薬剤バッグの膨れ変形を適当に調整(増幅若しくは縮小)して伝達可能である。   FIG. 7 shows a third embodiment. In this embodiment, a coupling tool that links the closing plug 30 that closes the discharge port 12 to the swelling deformation of the drug solution bag 10 when the weak seal portion 24 (partition wall) is opened is made of synthetic resin. The link mechanism 52 is used. The link mechanism 52 includes a plate-like portion (lever) 54 integrally formed with the closing plug 30, and first and second links 56-1, 56-connected to the plate-like portion 54 so as to be rotatable about a pivot 55. 2 and pivotally connected to the first and second links 56-1 and 56-2 by pivots 58-1 and 58-2, firmly with the plastic film facing layer constituting the drug solution bag 10 (cannot be peeled off) It consists of mounting plates 60-1 and 60-2 to be welded. The pivot 55, the links 56-1 and 56-2, the pivots 58-1 and 58-2, and the mounting plates 60-1 and 60-2 are formed of the same lightweight plastic material as that of the closing plug 30. By appropriately adjusting the length ratio between the lever 54 and the links 56-1 and 56-2, the swelling deformation of the drug bag can be adjusted (amplified or reduced) and transmitted.

図7(イ)は薬液バッグ未開通時を示しており、リンク機構52は閉鎖状態にあり、閉止栓30は排出ポート12を閉鎖している。   FIG. 7A shows a state in which the chemical solution bag is not opened, the link mechanism 52 is in a closed state, and the closing plug 30 closes the discharge port 12.

図7(ロ)は隔壁開通時を示しており、薬液バッグ10中の薬液は外部から加圧され、弱シール部(隔室)24が開通される。弱シール部24の開通による薬液バッグ10の膨れ変形は、取付板60-1, 60-2が薬液バッグ10の対向内層に強固に溶着されていることから、第1及び第2のリンク56-1, 56-2を外方に引張、閉止栓30は排出ポート12から離脱せしめられ、薬剤は排出ポート12に流入せしめられる。   FIG. 7 (b) shows when the partition wall is opened. The chemical solution in the chemical solution bag 10 is pressurized from the outside, and the weak seal portion (compartment) 24 is opened. The swelling deformation of the chemical solution bag 10 due to the opening of the weak seal portion 24 is because the mounting plates 60-1 and 60-2 are firmly welded to the opposed inner layer of the chemical solution bag 10, so that the first and second links 56- 1, 56-2 is pulled outward, the closing plug 30 is detached from the discharge port 12, and the medicine is allowed to flow into the discharge port 12.

図7(ハ)は隔壁開通後の状態を示し、分離した閉止栓30はプラスチック製で比重としては小さくかつ閉止栓30は枢軸55によりリンク56-1, 56-2に枢着され、リンク56-1, 56-2は枢軸58-1, 58-2により取付板60-1, 60-2に枢着されているため、閉止栓30は薬液バッグ10中の薬液に浮かび、排出ポート12から離間維持され、排出ポート12が閉塞されてしまうことはない。   FIG. 7C shows a state after the partition wall is opened. The separated stopper plug 30 is made of plastic and has a small specific gravity, and the stopper plug 30 is pivotally attached to the links 56-1 and 56-2 by the pivot 55. -1 and 56-2 are pivotally attached to the mounting plates 60-1 and 60-2 by pivots 58-1 and 58-2. Therefore, the closing plug 30 floats on the chemical solution in the chemical solution bag 10 and is discharged from the discharge port 12. The separation is maintained and the discharge port 12 is not blocked.

図8は別の実施形態を示しており、この実施形態では排出ポート12を閉鎖する閉止栓30を弱シール部14(隔壁)開通時の薬液バッグ10の膨れ変形に連動せしめる連結具をL型の剛体レバー62により構成している。剛体レバー62は一端は閉止栓30と一体に成形され、他端は一体成形のプレート部66により薬液バッグ10の対向面に強固に溶着されている。   FIG. 8 shows another embodiment. In this embodiment, an L-shaped connector is used for interlocking the stopper plug 30 for closing the discharge port 12 with the swelling deformation of the chemical bag 10 when the weak seal portion 14 (partition wall) is opened. The rigid lever 62 is used. One end of the rigid lever 62 is formed integrally with the closing plug 30, and the other end is firmly welded to the opposing surface of the drug solution bag 10 by an integrally formed plate portion 66.

図8(イ)は薬液バッグ未開通時を示しており、排出ポート12は閉止栓30により閉鎖されている。   FIG. 8 (a) shows a state in which the chemical solution bag is not opened, and the discharge port 12 is closed by a closing plug 30.

図8(ロ)は隔壁開通時を示しており、弱シール部の開通による薬液バッグ10の膨れ変形は、剛体レバー62を薬液バッグ10との溶着部において外方に変位させるが、剛体レバー62のL形状故に剛体レバー62の端部の閉止栓30は排出ポート12から離脱移動せしめられ、薬剤は排出ポート12に流入せしめられる。   FIG. 8B shows a state when the partition wall is opened. The swelling deformation of the chemical bag 10 due to the opening of the weak seal portion displaces the rigid lever 62 outward at the welded portion with the chemical bag 10. Therefore, the closing plug 30 at the end of the rigid lever 62 is moved away from the discharge port 12, and the medicine is allowed to flow into the discharge port 12.

図9は更に別の実施形態を示しており、この実施形態では排出ポート12を閉鎖する閉止栓30を末広がり形状の薄肉プラスチックの連結板64により構成している。薄肉連結板64は幅の狭い下端で閉止栓30から一体に延設され、幅の広い他端は両側端縁で薬液バッグ10の対向面に強固に溶着される。また、連結64は幅広端縁から幅の狭い閉止栓30の外周縁に沿った付根まで延びる薄肉の脆弱部68を形成している。   FIG. 9 shows still another embodiment. In this embodiment, a closing plug 30 for closing the discharge port 12 is constituted by a thin plastic connecting plate 64 having a divergent shape. The thin connecting plate 64 is integrally extended from the stopper plug 30 at the lower end of the narrow width, and the other end of the wide width is firmly welded to the opposing surface of the drug solution bag 10 at both side edges. Further, the connection 64 forms a thin fragile portion 68 extending from the wide end edge to the root along the outer peripheral edge of the narrow stopper plug 30.

図9(イ)は薬液バッグ未開通時を示しており、排出ポート12は閉止栓30により閉鎖されている。   FIG. 9A shows a state in which the chemical solution bag is not opened, and the discharge port 12 is closed by a closing plug 30.

図9(ロ)は隔壁開通時を示しており、弱シール部の開通による薬液バッグ10の膨れ変形は、連結板64をして脆弱部68にて破壊せしめ、薬液バッグの対向内層における一方に溶着された部分68-1と他方に溶着された部分68-2に分離され、それぞれの部分68-1, 68-2が薬剤バッグの膨れと連動して外方に変位するため、部分68-1と一体の閉止栓30は排出ポート12から離脱せしめられ、薬剤は排出ポート12に流入せしめられる。   FIG. 9 (b) shows the time when the partition wall is opened, and the swelling deformation of the chemical bag 10 due to the opening of the weak seal portion is caused by the connecting plate 64 to be broken at the fragile portion 68. Since the welded portion 68-1 and the welded portion 68-2 are separated, the respective portions 68-1, 68-2 are displaced outwardly in conjunction with the swelling of the drug bag. The closure plug 30 integrated with 1 is removed from the discharge port 12, and the medicine is allowed to flow into the discharge port 12.

図10は以上の閉止栓30を排出ポート12の軸線に沿って開放せしめる実施形態において、閉止栓30を介して少量の液漏れを起こさせ、複室容器製造時の滅菌を湿熱下で行われようにしたものである。即ち、閉止栓30は一体連結部30-1を介して、連結板32(図1)、内蔵バッグ42(図5)、リンク機構52(図7)、剛体レバー62(図8)、薄肉プラスチックの連結板64(図9)のような連結具に連接され、開通時の薬剤バッグの膨れ変形に連動して閉止栓30は開放せしめられる。そして、閉止栓30は排出ポート12に幾分の隙間70をもって挿入されている。また、排出ポート12の内周には排出ポート12の長手方向における閉止栓30の位置決めを行う突起部72, 74が設けられる。隙間70の設置により少量の液漏れがあるが、隙間70の開口面積は通常の輸液時の液量より少量となるため、薬液バッグ未開通で輸液されたとしても少量しか流れないため薬液バッグ未開通を気付かせることができる。薬液バッグ開通により閉止栓30は上方に変位し、突起74を乗り越えて、排出ポート12から抜去される。隙間70を介しての液漏れは複室容器製造時における湿熱下の効率的な滅菌を可能とする。   FIG. 10 shows an embodiment in which the above-described closing plug 30 is opened along the axis of the discharge port 12, and a small amount of liquid leakage is caused through the closing plug 30, and sterilization at the time of manufacturing the multi-chamber container is performed under wet heat. It is what I did. That is, the closing plug 30 is connected to the connecting plate 32 (FIG. 1), the built-in bag 42 (FIG. 5), the link mechanism 52 (FIG. 7), the rigid lever 62 (FIG. 8), and the thin plastic through the integrated connecting portion 30-1. The connecting plate 64 (FIG. 9) is connected to a connecting tool, and the stopper plug 30 is opened in conjunction with the swelling deformation of the medicine bag at the time of opening. The stopper plug 30 is inserted into the discharge port 12 with some gap 70. Further, on the inner periphery of the discharge port 12, projections 72 and 74 for positioning the stopper plug 30 in the longitudinal direction of the discharge port 12 are provided. Although there is a small amount of liquid leakage due to the installation of the gap 70, the opening area of the gap 70 is smaller than the liquid volume at the time of normal infusion. You can notice the opening. With the opening of the chemical solution bag, the closing plug 30 is displaced upward, gets over the protrusion 74 and is removed from the discharge port 12. Liquid leakage through the gap 70 enables efficient sterilization under wet heat when manufacturing a multi-chamber container.

図11は排出ポート12の内周に外開きのテーパ面12Aを設け、少量の液漏れを確保するようにしたものである。   In FIG. 11, an outwardly opening tapered surface 12A is provided on the inner periphery of the discharge port 12 to ensure a small amount of liquid leakage.

図1はこの発明の第1の実施形態の複室型容器の平面図である。FIG. 1 is a plan view of a multi-chamber container according to the first embodiment of the present invention. 図2は図1のII−II線に沿った複室型容器の断面図である。FIG. 2 is a cross-sectional view of the multi-chamber container taken along line II-II in FIG. 図3は図1における薄肉連結板の部分拡大図である。FIG. 3 is a partially enlarged view of the thin connecting plate in FIG. 図4は図2における排出ポートの部分図であるが、薬剤バッグ開通時を示している。FIG. 4 is a partial view of the discharge port in FIG. 図5はこの発明の第2の実施形態の複室型容器の平面図である。FIG. 5 is a plan view of a multi-chamber container according to the second embodiment of the present invention. 図6は図5のVI−VI線に沿った模式的断面図で、第2の実施形態の複室型容器の動作を示す。FIG. 6 is a schematic cross-sectional view taken along the line VI-VI in FIG. 5 and shows the operation of the multi-chamber container of the second embodiment. 図7は別実施形態の複室型容器の部分的断面図である。FIG. 7 is a partial cross-sectional view of a multi-chamber container according to another embodiment. 図8は更に別の実施形態の複室型容器の部分的断面図である。FIG. 8 is a partial cross-sectional view of a multi-chamber container according to still another embodiment. 図9は更に別の実施形態の複室型容器の部分的断面図である。FIG. 9 is a partial sectional view of a multi-chamber container according to still another embodiment. 図10はこの発明の複室型容器における別実施形態の閉止栓の、排出ポートに対する位置関係を説明する図である。FIG. 10 is a view for explaining the positional relationship of the closure plug according to another embodiment of the multi-chamber container of the present invention with respect to the discharge port. 図11は図10と同様であるが、更に別の実施形態の閉止栓を示す。FIG. 11 is similar to FIG. 10 but shows yet another embodiment of a closure plug.

符号の説明Explanation of symbols

10…薬剤バッグ
12…排出ポート
14…強シール部
20…ゴム栓
24…弱シール部(本発明の隔壁)
26, 28…第1及び第2の隔室
30…閉止栓
32…薄肉連結板(この発明の連結具)
34…スリット
36-1, 36-2…第1、第2連結部
38-1, 38-2…溶着部
42…内蔵バッグ
44-1, 44-2…内蔵バッグを形成する上下の合成樹脂フィルム
52…合成樹脂製リンク機構
62…剛体レバー
64…薄肉プラスチック連結板
68…薄肉の脆弱部
DESCRIPTION OF SYMBOLS 10 ... Drug bag 12 ... Discharge port 14 ... Strong seal part 20 ... Rubber stopper 24 ... Weak seal part (partition wall of this invention)
26, 28 ... 1st and 2nd compartment 30 ... Closure stopper 32 ... Thin connection board (connector of this invention)
34 ... Slit
36-1, 36-2 ... 1st and 2nd connecting part
38-1, 38-2 ... Welding part 42 ... Built-in bag
44-1, 44-2 ... Upper and lower synthetic resin films 52 forming a built-in bag ... Synthetic resin link mechanism 62 ... Rigid lever 64 ... Thin plastic connecting plate 68 ... Thin fragile portion

Claims (3)

軟弱フィルムにて形成された薬液バッグと、薬液バッグの対向面を加圧剥離可能に溶着することにより薬剤バッグの内部を複数の隔室に分離する隔壁と、薬液バッグに固定され、一端が薬液バッグの内部に延出し、薬液バッグの外側に位置する他端に穿刺のための栓体を具備した排出ポートと、薬剤バッグの内部に延出した排出ポートの前記一端に移動可能に設けられ、通常は排出ポートの前記一端に挿入されている閉鎖部材と、隔壁開通時の薬液バッグ拡開変位に連動して前記閉鎖部材を排出ポートから離脱移動せしめるべく前記閉鎖部材を薬液バッグを構成する軟弱フィルム内面に溶着にて連結する連結具とから構成される複室容器。   A drug bag formed of a soft film, a partition wall that separates the inside of the drug bag into a plurality of compartments by welding the opposite surfaces of the drug solution bag so as to be capable of being pressure-released, and one end fixed to the drug solution bag A discharge port that extends into the bag and has a stopper for puncture at the other end located outside the drug solution bag, and is movably provided at the one end of the discharge port that extends into the drug bag, Normally, the closing member inserted into the one end of the discharge port, and the softening that constitutes the chemical bag to move the closing member away from the discharge port in conjunction with the expansion of the chemical bag when the partition wall is opened A multi-chamber container composed of a connector connected to the inner surface of the film by welding. 請求項1に記載の発明において、排出ポートに対する前記閉鎖部材一端の挿入部に適宜な隙間を設けた複室容器。   2. The multi-chamber container according to claim 1, wherein an appropriate gap is provided in an insertion portion at one end of the closing member with respect to the discharge port. 請求項1若しくは2に記載の発明において、前記連結具は薄肉板材や、リンクや、レバーや、紐状体等の適宜な機構手段にて構成され、隔壁開通時の薬液バッグ拡開変位がそのまま若しくは増幅されて閉鎖部材に伝達される複室容器。   In the invention according to claim 1 or 2, the connector is constituted by an appropriate mechanism means such as a thin plate member, a link, a lever, a string-like body, etc., and the chemical bag expansion displacement at the time of opening the partition wall is left as it is. Alternatively, a multi-chamber container that is amplified and transmitted to the closure member.
JP2007183172A 2007-07-12 2007-07-12 Multi-chamber container Expired - Fee Related JP5141949B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007183172A JP5141949B2 (en) 2007-07-12 2007-07-12 Multi-chamber container

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007183172A JP5141949B2 (en) 2007-07-12 2007-07-12 Multi-chamber container

Publications (2)

Publication Number Publication Date
JP2009018038A true JP2009018038A (en) 2009-01-29
JP5141949B2 JP5141949B2 (en) 2013-02-13

Family

ID=40358194

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007183172A Expired - Fee Related JP5141949B2 (en) 2007-07-12 2007-07-12 Multi-chamber container

Country Status (1)

Country Link
JP (1) JP5141949B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011130862A (en) * 2009-12-23 2011-07-07 Nipro Corp Medical double-chamber container
WO2014103411A1 (en) * 2012-12-28 2014-07-03 味の素株式会社 Multi-chamber vessel
JP2015027414A (en) * 2012-12-28 2015-02-12 エイワイファーマ株式会社 Multi-chamber vessel

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03130683U (en) * 1990-04-11 1991-12-27
JPH10179686A (en) * 1996-12-25 1998-07-07 Takeda Chem Ind Ltd Infusion container
JP2007267877A (en) * 2006-03-30 2007-10-18 Terumo Corp Medical container

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03130683U (en) * 1990-04-11 1991-12-27
JPH10179686A (en) * 1996-12-25 1998-07-07 Takeda Chem Ind Ltd Infusion container
JP2007267877A (en) * 2006-03-30 2007-10-18 Terumo Corp Medical container

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011130862A (en) * 2009-12-23 2011-07-07 Nipro Corp Medical double-chamber container
WO2014103411A1 (en) * 2012-12-28 2014-07-03 味の素株式会社 Multi-chamber vessel
WO2014104281A1 (en) * 2012-12-28 2014-07-03 味の素株式会社 Multi-chamber vessel
JP2015027414A (en) * 2012-12-28 2015-02-12 エイワイファーマ株式会社 Multi-chamber vessel

Also Published As

Publication number Publication date
JP5141949B2 (en) 2013-02-13

Similar Documents

Publication Publication Date Title
JP5088604B2 (en) Drug storage sealing body
JP5418649B2 (en) Multi-chamber container
JP5191145B2 (en) Infusion bag
JP2007050085A (en) Medical container
JP5141949B2 (en) Multi-chamber container
JP2007209705A (en) Multi-chamber container
JP4299553B2 (en) Medical container
JP4535840B2 (en) Manufacturing method of medical multi-chamber container
TW201040083A (en) Multi-chamber container
JP5078385B2 (en) Medical container
JP4822860B2 (en) Medical multi-chamber container
JP2008061669A (en) Multi-chamber container
JP4599918B2 (en) Drug storage sealing body and method for forming drug storage sealing body
JP4412468B2 (en) MEDICAL MIXED CHEMICAL SOLID BODY AND SEALING METHOD
JP5223244B2 (en) Multi-chamber container
JPWO2007055355A1 (en) Multi-chamber container
CN201147491Y (en) Single tube riding saddle type member and single room bag with solid boat-shaped base liquid-filling tube
CN201147522Y (en) Single tube and riding saddle type double-chamber transfusion bag
JP4821971B2 (en) Drug storage sealing body and adhesive seal
JP2007185418A (en) Multi-chamber container
CN201186034Y (en) Three-tube saddle type solid boat-shaped base powder-filling tube double-chamber transfusion bag
CN201147484Y (en) Single tube and hollow boat type double-chamber transfusion bag with diamond-type base powder-filling tube member
JP2009154024A (en) Double-chamber container
JP5024526B2 (en) Multi-chamber container
JP4695866B2 (en) Plastic multi-chamber bag with small bag

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100319

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20120223

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120307

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120501

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20121025

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20121107

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20151130

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20151130

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees